{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:40:48Z","timestamp":1787020848479,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T00:00:00Z","timestamp":1639612800000},"content-version":"vor","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"IDIBAPS"},{"name":"CIBERES"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality worldwide despite correct antibiotic use. Corticosteroids have long been evaluated as a treatment option, but heterogeneous effects on survival have precluded their widespread implementation. We aimed to evaluate whether corticosteroids might improve clinical outcomes in patients with severe CAP and high inflammatory responses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study design and methods<\/jats:title>\n                    <jats:p>We analyzed two prospective observational cohorts of patients with CAP in Barcelona and Rome who were admitted to intensive care with a high inflammatory response. Propensity score (PS) matching was used to obtain balance among the baseline variables in both groups, and we excluded patients with viral pneumonia or who received hydrocortisone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 610 patients admitted with severe CAP, 198 (32%) received corticosteroids and 387 had major criteria for severe CAP. All patients had a baseline serum C-reactive protein above 15\u00a0mg\/dL. Patients who received corticosteroids were more commonly male, had more comorbidities (e.g., cancer or chronic obstructive pulmonary disease), and presented with significantly higher sequential organ failure assessment scores. Eighty-nine patients met major severity criteria (invasive mechanical ventilation and\/or septic shock) and were matched per group. Twenty-eight-day mortality was lower among patients receiving corticosteroids (16 patients, 18%) than among those not receiving them (28 patients, 31%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.037). After PS matching, corticosteroid therapy reduced the 28-day mortality risk in patients who met major severity criteria (hazard ratio (HR) 0.53, 95% confidence interval (CI) 0.29\u20130.98) (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.043). In patients who did not meet major severity criteria, no benefits were observed with corticosteroid use (HR 0.88 (95%CI 0.32\u20132.36).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Corticosteroid treatment may be of benefit for patients with CAP who have septic shock and\/or a high inflammatory response and requirement for invasive mechanical ventilation. Corticosteroids appear to have no impact on mortality when these features are not present.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-021-03840-x","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T08:02:35Z","timestamp":1639641755000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Real-world corticosteroid use in severe pneumonia: a propensity-score-matched study"],"prefix":"10.1186","volume":"25","author":[{"given":"A.","family":"Ceccato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Barbeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Oscanoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Tiseo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gabarrus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Di Giannatale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Nogas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cilloniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Menichetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Niederman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Falcone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5470-2978","authenticated-orcid":false,"given":"A.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,16]]},"reference":[{"issue":"9998","key":"3840_CR1","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/S0140-6736(15)60733-4","volume":"386","author":"E Prina","year":"2015","unstructured":"Prina E, Ranzani OT, Torres A. Community-acquired pneumonia. Lancet Lond Engl. 2015;386(9998):1097\u2013108.","journal-title":"Lancet Lond Engl"},{"issue":"4","key":"3840_CR2","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1183\/09031936.00163407","volume":"32","author":"PG Dambrava","year":"2008","unstructured":"Dambrava PG, Torres A, Vall\u00e8s X, Mensa J, Marcos MA, Pe\u00f1arroja G, et al. Adherence to guidelines\u2019 empirical antibiotic recommendations and community-acquired pneumonia outcome. Eur Respir J. 2008;32(4):892\u2013901.","journal-title":"Eur Respir J"},{"issue":"4","key":"3840_CR3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1056\/NEJM199701233360402","volume":"336","author":"MJ Fine","year":"1997","unstructured":"Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336(4):243\u201350.","journal-title":"N Engl J Med"},{"issue":"7","key":"3840_CR4","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","volume":"200","author":"JP Metlay","year":"2019","unstructured":"Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American thoracic society and infectious diseases society of America. Am J Respir Crit Care Med. 2019;200(7):e45-67.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"3840_CR5","doi-asserted-by":"publisher","first-page":"e0191721","DOI":"10.1371\/journal.pone.0191721","volume":"13","author":"M Ferrer","year":"2018","unstructured":"Ferrer M, Travierso C, Cilloniz C, Gabarrus A, Ranzani OT, Polverino E, et al. Severe community-acquired pneumonia: Characteristics and prognostic factors in ventilated and non-ventilated patients. PLoS ONE. 2018;13(1):e0191721.","journal-title":"PLoS ONE"},{"issue":"5","key":"3840_CR6","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1136\/thx.2007.086785","volume":"63","author":"R Men\u00e9ndez","year":"2008","unstructured":"Men\u00e9ndez R, Cavalcanti M, Reyes S, Mensa J, Martinez R, Marcos MA, et al. Markers of treatment failure in hospitalised community acquired pneumonia. Thorax. 2008;63(5):447\u201352.","journal-title":"Thorax"},{"issue":"Suppl 3","key":"3840_CR7","first-page":"iii69","volume":"66","author":"RN Jones","year":"2011","unstructured":"Jones RN, Farrell DJ, Mendes RE, Sader HS. Comparative ceftaroline activity tested against pathogens associated with community-acquired pneumonia: results from an international surveillance study. J Antimicrob Chemother. 2011;66(Suppl 3):iii69-80.","journal-title":"J Antimicrob Chemother"},{"issue":"16","key":"3840_CR8","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1056\/NEJMra050541","volume":"353","author":"T Rhen","year":"2005","unstructured":"Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids\u2013new mechanisms for old drugs. N Engl J Med. 2005;353(16):1711\u201323.","journal-title":"N Engl J Med"},{"issue":"4","key":"3840_CR9","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s00134-017-4967-x","volume":"44","author":"A Torres","year":"2018","unstructured":"Torres A, Ferrer M, Niederman MS. Adjuvant therapies in critical care: steroids in community-acquired pneumonia. Intensive Care Med. 2018;44(4):478\u201381.","journal-title":"Intensive Care Med"},{"issue":"1","key":"3840_CR10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s13054-016-1442-y","volume":"20","author":"E Prina","year":"2016","unstructured":"Prina E, Ceccato A, Torres A. New aspects in the management of pneumonia. Crit Care Lond Engl. 2016;20(1):267.","journal-title":"Crit Care Lond Engl"},{"issue":"4","key":"3840_CR11","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.ccm.2018.07.008","volume":"39","author":"A Ceccato","year":"2018","unstructured":"Ceccato A, Ferrer M, Barbeta E, Torres A. Adjunctive therapies for community-acquired pneumonia. Clin Chest Med. 2018;39(4):753\u201364.","journal-title":"Clin Chest Med"},{"key":"3840_CR12","doi-asserted-by":"crossref","unstructured":"Marti C, Grosgurin O, Harbarth S, Combescure C, Abbas M, Rutschmann O, et al. Adjunctive corticotherapy for community acquired pneumonia: a systematic review and meta-analysis. PLoS ONE [Internet]. 2015 Dec 7 [cited 2021 Mar 1];10(12). https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4671611\/","DOI":"10.1371\/journal.pone.0144032"},{"issue":"4","key":"3840_CR13","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/jac\/dkn283","volume":"62","author":"II Siempos","year":"2008","unstructured":"Siempos II, Vardakas KZ, Kopterides P, Falagas ME. Adjunctive therapies for community-acquired pneumonia: a systematic review. J Antimicrob Chemother. 2008;62(4):661\u20138.","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"3840_CR14","doi-asserted-by":"publisher","first-page":"e47926","DOI":"10.1371\/journal.pone.0047926","volume":"7","author":"W Nie","year":"2012","unstructured":"Nie W, Zhang Y, Cheng J, Xiu Q. Corticosteroids in the treatment of community-acquired pneumonia in adults: a meta-analysis. PLoS ONE. 2012;7(10):e47926.","journal-title":"PLoS ONE"},{"issue":"7","key":"3840_CR15","doi-asserted-by":"publisher","first-page":"519","DOI":"10.7326\/M15-0715","volume":"163","author":"RAC Siemieniuk","year":"2015","unstructured":"Siemieniuk RAC, Meade MO, Alonso-Coello P, Briel M, Evaniew N, Prasad M, et al. Corticosteroid therapy for patients hospitalized with community-acquired pneumonia: a systematic review and meta-analysis. Ann Intern Med. 2015;163(7):519\u201328.","journal-title":"Ann Intern Med"},{"key":"3840_CR16","doi-asserted-by":"crossref","unstructured":"Horita N, Otsuka T, Haranaga S, Namkoong H, Miki M, Miyashita N, et al. Adjunctive systemic corticosteroids for hospitalized community-acquired pneumonia: systematic review and meta-analysis 2015 update. Sci Rep [Internet]. 2015;5. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4571641\/","DOI":"10.1038\/srep14061"},{"issue":"1","key":"3840_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1378\/chest.15-1733","volume":"149","author":"Y-D Wan","year":"2016","unstructured":"Wan Y-D, Sun T-W, Liu Z-Q, Zhang S-G, Wang L-X, Kan Q-C. Efficacy and safety of corticosteroids for community-acquired pneumonia: a systematic review and meta-analysis. Chest. 2016;149(1):209\u201319.","journal-title":"Chest"},{"issue":"3","key":"3840_CR18","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/cid\/cix801","volume":"66","author":"M Briel","year":"2018","unstructured":"Briel M, Spoorenberg SMC, Snijders D, Torres A, Fernandez-Serrano S, Meduri GU, et al. Corticosteroids in patients hospitalized with community-acquired pneumonia: systematic review and individual patient data metaanalysis. Clin Infect Dis Off Publ Infect Dis Soc Am. 2018;66(3):346\u201354.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"7","key":"3840_CR19","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1001\/jama.2015.88","volume":"313","author":"A Torres","year":"2015","unstructured":"Torres A, Sibila O, Ferrer M, Polverino E, Menendez R, Mensa J, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA. 2015;313(7):677\u201386.","journal-title":"JAMA"},{"issue":"44 Suppl 2","key":"3840_CR20","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1086\/511159","volume":"1","author":"LA Mandell","year":"2007","unstructured":"Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis Off Publ Infect Dis Soc Am. 2007;1(44 Suppl 2):S27-72.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"3840_CR21","doi-asserted-by":"crossref","unstructured":"Vincent JL, Moreno R, Takala J, Willatts S, De Mendon\u00e7a A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707\u201310.","DOI":"10.1007\/BF01709751"},{"issue":"3","key":"3840_CR22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res. 2011;46(3):399\u2013424.","journal-title":"Multivar Behav Res"},{"issue":"1","key":"3840_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","volume":"70","author":"PR Rosenbaum","year":"1983","unstructured":"Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41\u201355.","journal-title":"Biometrika"},{"issue":"12","key":"3840_CR24","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1093\/aje\/kwj149","volume":"163","author":"MA Brookhart","year":"2006","unstructured":"Brookhart MA, Schneeweiss S, Rothman KJ, Glynn RJ, Avorn J, St\u00fcrmer T. Variable selection for propensity score models. Am J Epidemiol. 2006;163(12):1149\u201356.","journal-title":"Am J Epidemiol"},{"key":"3840_CR25","doi-asserted-by":"publisher","first-page":"b2393","DOI":"10.1136\/bmj.b2393","volume":"338","author":"JAC Sterne","year":"2009","unstructured":"Sterne JAC, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393.","journal-title":"BMJ"},{"key":"3840_CR26","doi-asserted-by":"crossref","unstructured":"Collet D. Modelling survival data in medical research. 2nd edn. London; 1994.","DOI":"10.1007\/978-1-4899-3115-3"},{"issue":"9977","key":"3840_CR27","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/S0140-6736(14)62447-8","volume":"385","author":"CA Blum","year":"2015","unstructured":"Blum CA, Nigro N, Briel M, Schuetz P, Ullmer E, Suter-Widmer I, et al. Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet Lond Engl. 2015;385(9977):1511\u20138.","journal-title":"Lancet Lond Engl"},{"issue":"1","key":"3840_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1513\/AnnalsATS.201806-419OC","volume":"16","author":"R Cangemi","year":"2019","unstructured":"Cangemi R, Falcone M, Taliani G, Calvieri C, Tiseo G, Romiti GF, et al. Corticosteroid use and incident myocardial infarction in adults hospitalized for community-acquired pneumonia. Ann Am Thorac Soc. 2019;16(1):91\u20138.","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"3840_CR29","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1164\/rccm.200406-808OC","volume":"171","author":"M Confalonieri","year":"2005","unstructured":"Confalonieri M, Urbino R, Potena A, Piattella M, Parigi P, Puccio G, et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med. 2005;171(3):242\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"3840_CR30","first-page":"CD007720","volume":"12","author":"A Stern","year":"2017","unstructured":"Stern A, Skalsky K, Avni T, Carrara E, Leibovici L, Paul M. Corticosteroids for pneumonia. Cochrane Database Syst Rev. 2017;12:CD007720.","journal-title":"Cochrane Database Syst Rev"},{"key":"3840_CR31","unstructured":"Wu W-F, Fang Q, He G-J. Efficacy of corticosteroid treatment for severe community-acquired pneumonia: a meta-analysis. Am J Emerg Med. 2017;"},{"issue":"11","key":"3840_CR32","doi-asserted-by":"publisher","first-page":"e0165942","DOI":"10.1371\/journal.pone.0165942","volume":"11","author":"J Bi","year":"2016","unstructured":"Bi J, Yang J, Wang Y, Yao C, Mei J, Liu Y, et al. Efficacy and safety of adjunctive corticosteroids therapy for severe community-acquired pneumonia in adults: an updated systematic review and meta-analysis. PLoS ONE. 2016;11(11):e0165942.","journal-title":"PLoS ONE"},{"issue":"3","key":"3840_CR33","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.ejcdt.2013.03.009","volume":"62","author":"RM Nafae","year":"2013","unstructured":"Nafae RM, Ragab MI, Amany FM, Rashed SB. Adjuvant role of corticosteroids in the treatment of community-acquired pneumonia. Egypt J Chest Dis Tuberc. 2013;62(3):439\u201345.","journal-title":"Egypt J Chest Dis Tuberc"},{"key":"3840_CR34","doi-asserted-by":"crossref","unstructured":"Pastores SM, Annane D, Rochwerg B, Esicm and the CGTF of S and. Guidelines for the Diagnosis and Management of Critical Illness-Related Corticosteroid Insufficiency (CIRCI) in Critically Ill Patients (Part II): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Crit Care Med. 2018;46(1):146.","DOI":"10.1097\/CCM.0000000000002840"},{"issue":"1","key":"3840_CR35","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/joim.12891","volume":"286","author":"SA Urwyler","year":"2019","unstructured":"Urwyler SA, Blum CA, Coslovsky M, Mueller B, Schuetz P, Christ-Crain M. Cytokines and Cortisol\u2014predictors of treatment response to corticosteroids in community-acquired pneumonia? J Intern Med. 2019;286(1):75\u201387.","journal-title":"J Intern Med"},{"issue":"9","key":"3840_CR36","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1007\/s00134-018-5332-4","volume":"44","author":"G Moreno","year":"2018","unstructured":"Moreno G, Rodr\u00edguez A, Reyes LF, Gomez J, Sole-Violan J, D\u00edaz E, et al. Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study. Intensive Care Med. 2018;44(9):1470\u201382.","journal-title":"Intensive Care Med"},{"key":"3840_CR37","doi-asserted-by":"crossref","unstructured":"Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384(8):693\u2013704.","DOI":"10.1056\/NEJMoa2021436"},{"key":"3840_CR38","unstructured":"Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis|Critical Care Medicine|JAMA|JAMA Network [Internet]. [cited 2021 Mar 10]. https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2770279"},{"issue":"13","key":"3840_CR39","doi-asserted-by":"publisher","first-page":"e14636","DOI":"10.1097\/MD.0000000000014636","volume":"98","author":"J Huang","year":"2019","unstructured":"Huang J, Guo J, Li H, Huang W, Zhang T. Efficacy and safety of adjunctive corticosteroids therapy for patients with severe community-acquired pneumonia: a systematic review and meta-analysis. Medicine (Baltimore). 2019;98(13):e14636.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"3840_CR40","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S2213-2600(19)30417-5","volume":"8","author":"J Villar","year":"2020","unstructured":"Villar J, Ferrando C, Mart\u00ednez D, Ambr\u00f3s A, Mu\u00f1oz T, Soler JA, et al. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med. 2020;8(3):267\u201376.","journal-title":"Lancet Respir Med"},{"issue":"3","key":"3840_CR41","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","volume":"43","author":"A Rhodes","year":"2017","unstructured":"Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304\u201377.","journal-title":"Intensive Care Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-021-03840-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-021-03840-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-021-03840-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T08:06:04Z","timestamp":1639641964000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-021-03840-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3840"],"URL":"https:\/\/doi.org\/10.1186\/s13054-021-03840-x","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"8 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The\u00a0ethics committees of the Hospital Clinic of Barcelona (Register: 5451) and of Policlinico Umberto I (register: 4065) approved the study and its publication. The need for written informed consent was waived because of the non-interventional design. Patient identities remained anonymous throughout.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have disclosed that they do not have any conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"432"}}